BIORA THERAPEUTICS INC (BIOR) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:BIOR • US74319F3055

0.5597 USD
-0.79 (-58.54%)
At close: Dec 10, 2024
0.579 USD
+0.02 (+3.45%)
After Hours: 12/10/2024, 8:09:45 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to BIOR. BIOR was compared to 525 industry peers in the Biotechnology industry. BIOR may be in some trouble as it scores bad on both profitability and health. BIOR is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • BIOR had negative earnings in the past year.
  • In the past year BIOR has reported a negative cash flow from operations.
  • BIOR had negative earnings in each of the past 5 years.
  • In the past 5 years BIOR always reported negative operating cash flow.
BIOR Yearly Net Income VS EBIT VS OCF VS FCFBIOR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 -50M -100M -150M -200M

1.2 Ratios

  • BIOR has a worse Return On Assets (-217.44%) than 91.15% of its industry peers.
Industry RankSector Rank
ROA -217.44%
ROE N/A
ROIC N/A
ROA(3y)-232.13%
ROA(5y)-209.25%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BIOR Yearly ROA, ROE, ROICBIOR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 0 -2K -4K -6K

1.3 Margins

  • BIOR does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BIOR Yearly Profit, Operating, Gross MarginsBIOR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 0 -1M -2M -3M

1

2. Health

2.1 Basic Checks

  • BIOR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • BIOR has less shares outstanding than it did 1 year ago.
  • BIOR has a better debt/assets ratio than last year.
BIOR Yearly Shares OutstandingBIOR Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M
BIOR Yearly Total Debt VS Total AssetsBIOR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 50M 100M 150M

2.2 Solvency

  • BIOR has an Altman-Z score of -116.59. This is a bad value and indicates that BIOR is not financially healthy and even has some risk of bankruptcy.
  • BIOR's Altman-Z score of -116.59 is on the low side compared to the rest of the industry. BIOR is outperformed by 98.05% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -116.59
ROIC/WACCN/A
WACC2.47%
BIOR Yearly LT Debt VS Equity VS FCFBIOR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 100M -100M

2.3 Liquidity

  • A Current Ratio of 0.05 indicates that BIOR may have some problems paying its short term obligations.
  • BIOR's Current ratio of 0.05 is on the low side compared to the rest of the industry. BIOR is outperformed by 99.29% of its industry peers.
  • BIOR has a Quick Ratio of 0.05. This is a bad value and indicates that BIOR is not financially healthy enough and could expect problems in meeting its short term obligations.
  • BIOR has a worse Quick ratio (0.05) than 99.29% of its industry peers.
Industry RankSector Rank
Current Ratio 0.05
Quick Ratio 0.05
BIOR Yearly Current Assets VS Current LiabilitesBIOR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

5

3. Growth

3.1 Past

  • BIOR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -22.72%.
  • BIOR shows a strong growth in Revenue. In the last year, the Revenue has grown by 8820.00%.
  • The Revenue for BIOR have been decreasing by -87.44% on average. This is quite bad
EPS 1Y (TTM)-22.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%89.69%
Revenue 1Y (TTM)8820%
Revenue growth 3Y-72.86%
Revenue growth 5Y-87.44%
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 24.30% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, BIOR will show a very strong growth in Revenue. The Revenue will grow by 933.87% on average per year.
EPS Next Y88.79%
EPS Next 2Y38.19%
EPS Next 3Y24.3%
EPS Next 5YN/A
Revenue Next Year39100%
Revenue Next 2Y3064.14%
Revenue Next 3Y933.87%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
BIOR Yearly Revenue VS EstimatesBIOR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M
BIOR Yearly EPS VS EstimatesBIOR Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 -500 -1K -1.5K

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for BIOR. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BIOR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BIOR Price Earnings VS Forward Price EarningsBIOR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BIOR Per share dataBIOR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10 -15 -20

4.3 Compensation for Growth

  • A more expensive valuation may be justified as BIOR's earnings are expected to grow with 24.30% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.19%
EPS Next 3Y24.3%

0

5. Dividend

5.1 Amount

  • BIOR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BIORA THERAPEUTICS INC / BIOR FAQ

What is the fundamental rating for BIOR stock?

ChartMill assigns a fundamental rating of 2 / 10 to BIOR.


What is the valuation status of BIORA THERAPEUTICS INC (BIOR) stock?

ChartMill assigns a valuation rating of 1 / 10 to BIORA THERAPEUTICS INC (BIOR). This can be considered as Overvalued.


What is the profitability of BIOR stock?

BIORA THERAPEUTICS INC (BIOR) has a profitability rating of 0 / 10.